Credit Suisse Ag Moderna, Inc. Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

A detailed history of Credit Suisse Ag transactions in Moderna, Inc. stock. As of the latest transaction made, Credit Suisse Ag holds 539,488 shares of MRNA stock, worth $16.8 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

539,488

Previous 852,032 36.68%

Holding current value

$16.8 Million

Previous $84.7 Million 32.16%

% of portfolio

0.06%

Previous 0.08%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$85.37 - $115.44 $26.7 Million - $36.1 Million	-312,544 Reduced 36.68%	539,488 $57.5 Million
Q4 2023 Feb 08, 2024	SELL	$69.51 - $104.43 $5.73 Million - $8.6 Million	-82,397 Reduced 8.82%	852,032 $84.7 Million
Q3 2023 Nov 13, 2023	BUY	$96.41 - $126.61 $14.6 Million - $19.1 Million	150,932 Added 19.26%	934,429 $96.5 Million
Q2 2023 Aug 11, 2023	BUY	$118.5 - $160.53 $9.33 Million - $12.6 Million	78,700 Added 11.17%	783,497 $95.2 Million
Q1 2023 May 10, 2023	BUY	$135.66 - $197.02 $16.5 Million - $24 Million	121,742 Added 20.88%	704,797 $108 Million
Q4 2022 Feb 13, 2023	SELL	$118.38 - $210.04 $20.8 Million - $36.9 Million	-175,825 Reduced 23.17%	583,055 $105 Million
Q3 2022 Nov 10, 2022	SELL	$118.07 - $194.18 $19.4 Million - $31.9 Million	-164,227 Reduced 17.79%	758,880 $89.7 Million
Q2 2022 Aug 12, 2022	BUY	$117.13 - $176.59 $23.3 Million - $35.2 Million	199,346 Added 27.54%	923,107 $132 Million
Q1 2022 May 16, 2022	SELL	$126.46 - $235.05 $19.1 Million - $35.6 Million	-151,341 Reduced 17.29%	723,761 $125 Million
Q4 2021 Feb 14, 2022	SELL	$225.82 - $368.51 $53.1 Million - $86.6 Million	-234,979 Reduced 21.17%	875,102 $222 Million
Q3 2021 Nov 12, 2021	SELL	$221.9 - $484.47 $22.2 Million - $48.5 Million	-100,211 Reduced 8.28%	1,110,081 $427 Million
Q2 2021 Aug 16, 2021	SELL	$129.91 - $234.98 $15.2 Million - $27.5 Million	-117,069 Reduced 8.82%	1,210,292 $284 Million
Q1 2021 May 14, 2021	SELL	$109.18 - $185.98 $43.5 Million - $74.1 Million	-398,619 Reduced 23.1%	1,327,361 $174 Million
Q4 2020 Feb 12, 2021	BUY	$65.74 - $169.86 $25.3 Million - $65.4 Million	385,031 Added 28.71%	1,725,980 $180 Million
Q3 2020 Nov 13, 2020	BUY	$54.34 - $94.85 $4.37 Million - $7.62 Million	80,382 Added 6.38%	1,340,949 $94.9 Million
Q2 2020 Aug 12, 2020	SELL	$29.67 - $80.0 $12.4 Million - $33.4 Million	-417,781 Reduced 24.89%	1,260,567 $80.9 Million
Q1 2020 May 13, 2020	SELL	$17.78 - $31.58 $21.4 Million - $38.1 Million	-1,205,563 Reduced 41.8%	1,678,348 $50.3 Million
Q4 2019 Feb 12, 2020	BUY	$13.93 - $21.28 $4.02 Million - $6.14 Million	288,707 Added 11.12%	2,883,911 $56.4 Million
Q3 2019 Nov 12, 2019	BUY	$12.26 - $18.07 $6.03 Million - $8.89 Million	491,879 Added 23.39%	2,595,204 $41.3 Million
Q2 2019 Aug 14, 2019	BUY	$13.7 - $28.34 $14.4 Million - $29.8 Million	1,051,116 Added 99.9%	2,103,325 $30.8 Million
Q1 2019 May 14, 2019	BUY	$14.45 - $23.7 $6.53 Million - $10.7 Million	452,209 Added 75.37%	1,052,209 $21.4 Million
Q4 2018 Feb 13, 2019	BUY	$13.52 - $18.8 $8.11 Million - $11.3 Million	600,000 New	600,000 $9.16 Million

Others Institutions Holding MRNA

# of Institutions

923

Shares Held

255M

Call Options Held

19M

Put Options Held

24.3M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $12.2B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account